The American Academy of Ophthalmology serves as the leading professional organization for ophthalmologists in the United States. It focuses on promoting excellence in eye care through education, research, and advocacy initiatives aimed at improving patient outcomes in vision health.
The organization conducts a wide range of activities including the hosting of its annual meeting, which attracts thousands of eye care professionals from around the world to share the latest advancements in ophthalmic science and technology. It also develops clinical practice guidelines, provides continuing medical education opportunities, and supports research grants in the field of ophthalmology.
Based in San Francisco, the American Academy of Ophthalmology operates as a non-profit membership organization. Its membership includes ophthalmologists, researchers, and other eye care specialists who benefit from its resources and networking opportunities. The group structure is governed by elected officers and a board that oversees its strategic direction.
In the broader industry, the American Academy of Ophthalmology holds a prominent position as a key influencer in setting standards for ophthalmic practice and policy. It collaborates with government bodies, other medical associations, and industry partners to address challenges such as access to care, emerging treatments for eye diseases, and public awareness of vision-related issues. This positions it as a central hub for knowledge dissemination and professional development in ophthalmology.
None yet. When a new project in the record names AAO as owner, partner or investor, it shows here.
Remigromig met non-inferiority for mean BCVA change versus monthly ranibizumab at one year in DME; higher rates of PDR-related adverse events and discontinuations were reported.
